Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-01 15:31:19 - browse：2821

STAT

What if CRISPR isn’t all that commercial? How does the NurOwn story end? And how do you pronounce “Bayer”?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Live from Boston at the 2023 STAT Summit, we discuss the latest news in the life sciences, including a milestone in genome editing, a twist in the search for ALS treatments, and the polarizing process of saying words in biotech.

For more on what we cover, here’s the latest from the Summit; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Listen: Biogen's potential pivot, & Illumina's next chapter

leisure time

WSS

Smaller biotechs seek to piggyback on weight loss drug boom

Roche drug slashes death risk in early

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Health tech investors get more selective as pandemic boom fades

Is there really a nursing shortage in the U.S.?

STAT Summit: The economic case for universal basic health care

explore

Wikipedia

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Wildfire smoke exposes gaps in outdoor worker protections

STAT Summit: How researchers deal with rejection

Novavax promises a turnaround & Lilly roils the obesity market

Snackable artificial intelligence, expert AI, and the pharma industry

What does generative AI mean for health care? We asked experts

AstraZeneca chief proposes a novel edit to the drug pricing bill

Dobbs anniversary: the lost opportunity of abortion as health care

STAT Summit: How researchers deal with rejection

hotspot

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Merck, Daiichi strike cancer drug pact worth up to $22 billion

UnitedHealth, Optum discontinue NaviHealth name

How to fix cancer clinical trials' diversity problem

How AI can help patients find reliable information about doctors

Roche acquires Telavant from Roivant, adding experimental IBD treatment

hotspot

knowledge

leisure time

hotspot